COMMUNIQUÉS West-GlobeNewswire

DiaMedica Therapeutics Completes Non-Brokered Private Placement

19/12/2017 - 01:41

MINNEAPOLIS, Dec. 18, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX-V: DMA ) (OTCQB:DMCAF) announced today the closing of its previously announced non-brokered private placement raising [...]

Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu™ Vaccine

18/12/2017 - 22:32

RSV F Vaccine informational analysis completed in fourth quarter of 2017 RSV F Vaccine interim analysis expected mid-2018 with approximately 4,600 enrollees Filing of RSV F Vaccine BLA anticipated by late 2019 NanoFlu [...]

Amarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco

18/12/2017 - 22:30

BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Alpha Pro Tech, Ltd. Announces Passing of Al Millar, Founder, President and Chairman

18/12/2017 - 22:15

NOGALES, Ariz., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American:APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]

Oncolix, Inc., Announces Approval for Listing on OTC-QB

18/12/2017 - 22:10

HOUSTON, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTC PINK:ONCX) announced today that the Company has been given approval by the OTC Markets to be listed and traded on the OTC-QB effective at the opening of [...]

Flexion Therapeutics Enrolls First Patient in Study Evaluating the Pharmacokinetics and Safety of ZILRETTA™ (triamcinolone acetonide extended-release injectable suspension) in Osteoarthritis of the Shoulder and Hip

18/12/2017 - 22:05

BURLINGTON, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) announced today that it has enrolled the first patient in a clinical trial to evaluate the pharmacokinetics and safety of [...]

argenx announces closing of U.S. public offering for gross proceeds of approximately $266 million

18/12/2017 - 22:01

Regulated information December 18, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based [...]

Zephyr Health’s Relationship Analytics Named a Top Innovative Product of 2017 by PM360

18/12/2017 - 21:32

SAN FRANCISCO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Zephyr Health, the leading Insights-as-a-Service solution provider for Life Sciences companies, today announced that Zephyr Illuminate™ has been selected as one of the [...]

Harkesh Sandhu, MD is Honored by the American Health Council for “Best in Medicine”

18/12/2017 - 17:48

NEW YORK, Dec. 18, 2017 (GLOBE NEWSWIRE) -- The American Health Council is honored to name Harkesh Sandhu, MD as one of “America’s Best Doctors” for his unparalleled professional dedication and extraordinary [...]

Ossur Hf : Transactions in relation to share buyback program

18/12/2017 - 17:01

Announcement from Össur hf. No. 88/2017 Reykjavík, 18 December 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Tauriga Sciences, Inc. and Ice + Jam LLC Confirm the Arrival of Commercial Grade “HerMan” Product Inventory from Manufacturer

18/12/2017 - 16:45

NEW YORK, NY, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of proprietary [...]

Orion Corporation: Managers' transactions - Huhta-Koivisto Eemeli

18/12/2017 - 16:16

ORION CORPORATION MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 17.15 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Eemeli Orion Corporation has received the following disclosure under Market Abuse [...]

Emblem Corp. Launches Leading Line of Cannabis Oils to Meet Growing Demand and Drive Patient Acquisition

18/12/2017 - 16:13

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) , one of the [...]

The Painful Side Effect to Gifting Gadgets this Holiday Season

18/12/2017 - 16:00

SCOTTSDALE, Ariz., Dec. 18, 2017 (GLOBE NEWSWIRE) -- If you have a new phone or the latest video game console wrapped beneath your tree, you may also be giving a painful gift to your loved ones this holiday season. Text [...]

The Painful Side Effect to Gifting Gadgets this Holiday Season

18/12/2017 - 16:00

ALBUQUERQUE, N.M., Dec. 18, 2017 (GLOBE NEWSWIRE) -- If you have a new phone or the latest video game console wrapped beneath your tree, you may also be giving a painful gift to your loved ones this holiday season. Text [...]

Coloplast acquires SAS Lilial

18/12/2017 - 15:28

Today Coloplast A/S acquires the French direct-to-consumer home delivery company SAS Lilial (Lilial) for a cash consideration of EUR 35.5m equal to approx. DKK 264m. Lilial is a privately owned, French direct-to [...]

Announcement no. 13/2017 - Coloplast A/S acquires SAS Lilial

18/12/2017 - 15:27

Coloplast A/S acquires SAS Lilial Coloplast A/S announced today that it has entered into a definitive agreement to acquire SAS Lilial (Lilial) for a cash consideration of EUR 35.5m equal to approx. DKK 264m on a cash [...]

Board of Olainfarm Will be Chaired by Olegs Grigorjevs

18/12/2017 - 15:27

Olaine, 2017-12-18 15:27 CET (GLOBE NEWSWIRE) -- Olegs Grigorjevs was Executive Director of AS Olainfarm and the Member of the Board with more than 20 years of experience in chemical and pharmaceutical sector. O. [...]

PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018

18/12/2017 - 15:15

NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and [...]